CareDx, Inc. CDNA
81.17 USD +0.40 (+0.50%)
At closeNov 11, 2026, 4:00 PM EST
81.17 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
80.18 Day range 84.10
15.15 52-week range 90.87
- YTD
- +330.84%
- 1 year
- +383.73%
News
benzinga.com This Zebra Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday Analysts initiated coverage: Buy ratings for ZBRA and GLW, Overweight for CDNA, and Hold ratings for GWRE and ST, with price targets issued.
benzinga.com Piper Sandler Initiates Coverage On CareDx with Overweight Rating, Announces Price Target of $100 Piper Sandler analyst David Westenberg initiates coverage on CareDx (NASDAQ:CDNA) with a Overweight rating and announces Price Target of $100.
businesswire.com CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced the award of…
zacks.com CareDx (CDNA) Upgraded to Strong Buy: Here's What You Should Know CareDx (CDNA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
seekingalpha.com Polen 5Perspectives Ultra-Small Growth Q3 2026 Portfolio Review The top contributors to the Portfolio's relative performance in the quarter were Kodiak Sciences, Flotek Industries, and Hyperliquid Strategies. The most significant detractors from the Portfolio's…
seekingalpha.com Baron Discovery Fund Q3 2026 Portfolio Activity During the quarter, we initiated a position in Jersey Mike's Subs Inc., a franchisor of fast casual, submarine-style sandwich restaurants. We participated in the IPO of Lyntris Inc., a fast-growing…
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers CareDx (NASDAQ:CDNA) shares rose 22.2% to $87.42 during Friday's regular session. The company's market cap stands at $3.7 billion. As per the press release, Q3 earnings came out yesterday.…
benzinga.com AutoNation, Regeneron Pharmaceuticals, AstraZeneca And Other Big Stocks Moving Higher On Friday U.S. stocks fell Friday, but AutoNation jumped 8% after beating Q3 estimates; OneSpan, Grid Dynamics and others posted double-digit gains.
benzinga.com Why Civeo Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket Civeo shares surged 19.9% after earnings beat estimates and FY2026 sales guidance rose; other premarket movers included SLGB, HUBC and ATEC.
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 16.1% to $0.92 during Thursday's after-market session. The company's market cap stands at $2.2 million. CareDx (NASDAQ:CDNA) stock rose 15.0% to…
benzinga.com CareDx Raises FY2026 Sales Guidance from $490.000M-$500.000M to $520.000M-$530.000M vs $489.692M Est CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $490.000 million-$500.000 million to $520.000 million-$530.000 million vs $489.692 million estimate.
benzinga.com CareDx Q3 Adj. EPS $0.70 Beats $0.25 Estimate, Sales $139.362M Beat $120.608M Estimate CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.25 by 180 percent. This is a 150 percent increase over earnings of $0.28 per share…- benzinga.com Canaccord Genuity Maintains Buy on CareDx, Raises Price Target to $80 Canaccord Genuity analyst Kyle Mikson maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $65 to $80.
benzinga.com Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up Cathie Wood's ARK dumps $18M of Twist Bioscience while buying Recursion, Veracyte and Intellia, extending its CRISPR bet to 50 sessions.
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.
benzinga.com Canaccord Genuity Initiates Coverage On CareDx with Buy Rating, Announces Price Target of $65 Canaccord Genuity analyst Kyle Mikson initiates coverage on CareDx (NASDAQ:CDNA) with a Buy rating and announces Price Target of $65.
benzinga.com CNH Industrial Posts Upbeat Q2 Earnings, Joins Autolus Therapeutics, Bowhead Specialty Holdings And Other Big Stocks Moving Higher On Monday Dow Jones index gained 600 points, CNH Industrial rose 16% after reporting better-than-expected Q2 results, other stocks also recording gains.
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers Replimune Group (NASDAQ:REPL) stock rose 96.1% to $10.61 during Friday's regular session. SCYNEXIS (NASDAQ:SCYX) stock moved upwards by 22.54% to $4.57. The market value of their outstanding…- benzinga.com HC Wainwright & Co. Reiterates Neutral on CareDx, Maintains $46 Price Target HC Wainwright & Co. analyst Yi Chen reiterates CareDx (NASDAQ:CDNA) with a Neutral and maintains $46 price target.
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Scribe Therapeutics (NASDAQ:SCTX) shares increased by 12.7% to $23.0 during Thursday's after-market session. The market value of their outstanding shares is at $297.1 million. uniQure…
benzinga.com CareDx Q2 Adj. EPS $0.37 Beats $0.23 Estimate, Sales $131.948M Beat $114.044M Estimate CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.23 by 60.87 percent. This is a 270 percent increase over earnings of $0.10 per…- benzinga.com CareDx Raises FY2026 Sales Guidance from $447.000M-$465.000M to $490.000M-$500.000M vs $455.924M Est CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $447.000 million-$465.000 million to $490.000 million-$500.000 million vs $455.924 million estimate.
benzinga.com Why Is CareDx Stock Skyrocketing Thursday? CareDx ($CDNA) shares surge 28% as Medicare finalizes continued coverage for its kidney, heart, and lung transplant tests.- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's regular session. The company's market cap stands at $7.6 million. Agape ATP (NASDAQ:ATPC) shares moved…
benzinga.com Abbott Laboratories, AtaiBeckley, ManpowerGroup And Other Big Stocks Moving Higher On Thursday U.S. stocks mixed, Nasdaq falls 150 points. Abbott Labs beats Q2 estimates and raises guidance, stock jumps 12.1%. Other big gainers include ATAI, MAN, DSGR, CDNA, MAAS, HELP, RHI, SMG, FWRD, UNH,…- benzinga.com CareDx Finalizes Medicare Local Coverage Determination Procedure Regarding Molecular Testing For Solid Organ Allograft Rejection CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced the finalization of the Medicare Local Coverage…
- benzinga.com CareDx Completes Sale Of Its Lab Products Operations To Eurobio Scientific For $171.2M CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value…
benzinga.com CareDx's 2021 Qui Tam Action Dismissed; No Monetary Payment Associated With Dismissal CareDx, Inc. (NASDAQ:CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value…
benzinga.com CareDx Files For Mixed Shelf; Size Not Disclosed CareDx, Inc.Common StockPreferred StockDebt SecuritiesWarrantsSubscription RightsUnitsWe may offer and sell, from time to time in one or more offerings, shares of our common stock or preferred…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com CareDx Strikes Agreement To Acquire Naveris For $160M Upfront Payment, $100M In Future Milestones CareDx, Inc. (NASDAQ:CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value…- benzinga.com CareDx Raises FY2026 Sales Guidance from $420.000M-$444.000M to $447.000M-$465.000M vs $436.665M Est CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $420.000 million-$444.000 million to $447.000 million-$465.000 million vs $436.665 million estimate.
- benzinga.com CareDx Q1 Adj. EPS $0.34 Beats $0.13 Estimate, Sales $117.700M Beat $104.034M Estimate CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.13 by 161.54 percent. This is a 277.78 percent increase over earnings of $0.09 per…
benzinga.com Earnings Scheduled For April 28, 2026 - benzinga.com CareDx Launches New Test That Matches Organ Donors and Patients in Under 3 Hours, Unveils AlloSeq Nano With 45-Minute Prep and Faster, More Accurate Transplant Matching CareDx, Inc. (NASDAQ:CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value…
benzinga.com CareDx Sharpens Focus On Core Testing Services CareDx Inc. (CDNA) sells Lab Products business to EuroBio Scientific for $170 million in cash, focusing on higher-growth precision testing and digital solutions.- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com Aehr Test Systems, CareDx, Okta And Other Big Stocks Moving Higher On Thursday U.S. stocks were mixed on Thursday, with the Dow Jones gaining 0.1%. Aehr Test Systems shares rose 15.6% following a $41M production order from an AI customer. Other big gainers include Xanadu…- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com CareDx Signs Agreement With EuroBio Scientific To Divest Lab Products Operations For $170M In Cash; Reports Preliminary Q1 Revenue ~$118M, Up 39% YoY CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value…
- benzinga.com Earnings Scheduled For February 24, 2026
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com Earnings Scheduled For November 4, 2025 
benzinga.com This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday - benzinga.com Earnings Scheduled For August 6, 2025
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session - benzinga.com Earnings Scheduled For April 30, 2025
benzinga.com Why Xos Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket